Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Combining motor imagery and watching action videos to improve upper‑limb function in female breast cancer survivors

Official title: Effectiveness of Combined Motor Imagery and Action Observation in Improving Pain, Range of Motion, and Upper Limb Lymphedema in Breast Cancer Survivors. Efectividad de Las Terapias de imaginería Motora y observación de la acción en la Mejora Del Dolor, la Movilidad y el Linfedema de la Extremidad Superior en Supervivientes de cáncer de Mama.

Run by Fundacion Miguel Servet · NCT07067710 · Data updated 2026-11-12

This trial will test whether combining motor imagery with watching action videos can help improve arm strength, range of motion, pain, swelling, or fear of movement in women who have completed breast cancer treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment108 (estimated)
SponsorFundacion Miguel Servet
Academic / other
Drugs / interventionschemotherapy
Locations3 sites (Pamplona, Navarre and 2 other locations)
StatusRecruiting
StartedFebruary 25, 2025
Main results expectedApril 28, 2025
Study endsFebruary 2026
Registry record updatedJuly 16, 2025
Trial IDNCT07067710 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women over 18 who have completed active breast cancer treatment and have upper‑limb pain, functional limitation, or lymphedema are the intended participants.

Probably not a fit

Men, people still receiving active cancer treatment, those with recurrent or metastatic disease, or patients without upper‑limb symptoms are unlikely to benefit from or be eligible for this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial comparing an intervention program that pairs action observation (watching videos of upper‑limb movements) with motor imagery and actual practice, versus usual care. Female breast cancer survivors with upper‑limb pain, functional limitation, or lymphedema who have finished active treatment will be enrolled and randomly assigned. Outcomes will be measured before and after the intervention using tools such as a dynamometer for strength, a goniometer for range of motion, a Visual Analogue Scale for pain, limb diameter measures, and the Tampa Scale for Kinesiophobia. Investigators will compare changes between the intervention and control groups to see if the combined protocol produces greater functional gains.

Why it matters

Potential benefit: If successful, this combined therapy could reduce pain and fear of movement and improve arm strength, range of motion, and functional use of the affected limb for survivors.

How similar studies have gone: Motor imagery and action observation have shown benefit in stroke and orthopedic rehabilitation, but combined protocols in breast cancer survivor populations remain relatively novel with limited prior trial data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female, over 18 years, have suffered breast cancer, have ended active treatments (chemotherapy, radiotherapy, surgery), have pain or functional limitation or lymphedema at upper limb afected.

Exclusion Criteria:

* males, people with active treatments ongoning, other types of cancer, recurrence or metastasis of cancer

Where it's running

  • Public University of Navarre
    Pamplona, Navarre, Spain
    Recruiting
  • Public University of Navarre
    Pamplona, Navarre, Spain
    Recruiting
  • Public University of Navarre
    Pamplona, Navarre, Spain
    Not yet recruiting

Study contacts

  • Principal investigator: Pilar Arnal-Vallés, Candidate PhD — Hospital of Navarra
  • Study coordinator: Pilar Arnal-Vallés, Candidate PhD
  • Email: pilararnal3b@gmail.com
  • Phone: +34 948166117

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.